These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 39329149)

  • 1. Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles.
    Nielsen IH; Rovsing AB; Janns JH; Thomsen EA; Ruzo A; Bøggild A; Nedergaard F; Møller CT; Boesen T; Degn SE; Shah JV; Mikkelsen JG
    Mol Ther Nucleic Acids; 2024 Dec; 35(4):102318. PubMed ID: 39329149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification.
    Haldrup J; Andersen S; Labial ARL; Wolff JH; Frandsen FP; Skov TW; Rovsing AB; Nielsen I; Jakobsen TS; Askou AL; Thomsen MK; Corydon TJ; Thomsen EA; Mikkelsen JG
    Nucleic Acids Res; 2023 Oct; 51(18):10059-10074. PubMed ID: 37678882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.
    Frecha C; Lévy C; Costa C; Nègre D; Amirache F; Buckland R; Russell SJ; Cosset FL; Verhoeyen E
    J Virol; 2011 Jun; 85(12):5975-85. PubMed ID: 21450813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells.
    Humbert JM; Frecha C; Amirache Bouafia F; N'Guyen TH; Boni S; Cosset FL; Verhoeyen E; Halary F
    J Virol; 2012 May; 86(9):5192-203. PubMed ID: 22345444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins.
    Schoenhals M; Frecha C; Bruyer A; Caraux A; Veyrune JL; Jourdan M; Moreaux J; Cosset FL; Verhoeyen E; Klein B
    Leukemia; 2012 Jul; 26(7):1663-70. PubMed ID: 22318450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity.
    Funke S; Schneider IC; Glaser S; Mühlebach MD; Moritz T; Cattaneo R; Cichutek K; Buchholz CJ
    Gene Ther; 2009 May; 16(5):700-5. PubMed ID: 19212424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting lymphocyte transduction with measles virus glycoprotein pseudotyped lentiviral vectors relies on CD46 and SLAM.
    Zhou Q; Schneider IC; Gallet M; Kneissl S; Buchholz CJ
    Virology; 2011 May; 413(2):149-52. PubMed ID: 21470651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.
    Frecha C; Costa C; Nègre D; Gauthier E; Russell SJ; Cosset FL; Verhoeyen E
    Blood; 2008 Dec; 112(13):4843-52. PubMed ID: 18812471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy.
    Gutierrez-Guerrero A; Cosset FL; Verhoeyen E
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32933033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor Cells.
    Ozog S; Chen CX; Simpson E; Garijo O; Timberlake ND; Minder P; Verhoeyen E; Torbett BE
    Mol Ther Methods Clin Dev; 2019 Jun; 13():27-39. PubMed ID: 30603655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
    Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
    Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.
    Lévy C; Amirache F; Costa C; Frecha C; Muller CP; Kweder H; Buckland R; Cosset FL; Verhoeyen E
    Mol Ther; 2012 Sep; 20(9):1699-712. PubMed ID: 22617109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein.
    Hashimoto K; Ono N; Tatsuo H; Minagawa H; Takeda M; Takeuchi K; Yanagi Y
    J Virol; 2002 Jul; 76(13):6743-9. PubMed ID: 12050387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis.
    Shingai M; Ayata M; Ishida H; Matsunaga I; Katayama Y; Seya T; Tatsuo H; Yanagi Y; Ogura H
    J Gen Virol; 2003 Aug; 84(Pt 8):2133-2143. PubMed ID: 12867645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Multi-Allelic Genome Editing of Primary Cell Cultures via CRISPR-Cas9 Ribonucleoprotein Nucleofection.
    Hoellerbauer P; Kufeld M; Paddison PJ
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e126. PubMed ID: 32833346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins.
    Enkirch T; Kneissl S; Hoyler B; Ungerechts G; Stremmel W; Buchholz CJ; Springfeld C
    Gene Ther; 2013 Jan; 20(1):16-23. PubMed ID: 22218301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
    Lyu P; Javidi-Parsijani P; Atala A; Lu B
    Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins.
    Marino MP; Panigaj M; Ou W; Manirarora J; Wei CH; Reiser J
    Gene Ther; 2015 Mar; 22(3):280-5. PubMed ID: 25608718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
    Kneissl S; Abel T; Rasbach A; Brynza J; Schneider-Schaulies J; Buchholz CJ
    PLoS One; 2012; 7(10):e46667. PubMed ID: 23071609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.